Grown Rogue International Inc. (GRIN.CN)
CAD 0.66
(-1.49%)
CAD 0.66
(-1.49%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.13 Million USD | -164.26% |
| 2022 | 3.32 Million USD | -3.72% |
| 2021 | 3.45 Million USD | 41.72% |
| 2020 | 2.43 Million USD | 10.2% |
| 2019 | 2.21 Million USD | 34.06% |
| 2018 | 1.65 Million USD | -18.64% |
| 2017 | 2.02 Million USD | 690.19% |
| 2016 | -343.74 Thousand USD | -133.21% |
| 2015 | 1.03 Million USD | 28.08% |
| 2014 | 808.04 Thousand USD | 4.36% |
| 2013 | 774.28 Thousand USD | -72.51% |
| 2012 | 2.81 Million USD | -27.14% |
| 2011 | 3.86 Million USD | 252.17% |
| 2010 | 1.09 Million USD | 20404.61% |
| 2009 | -5405.00 USD | 97.17% |
| 2008 | -190.83 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -950.79 Thousand USD | 46.47% |
| 2024 Q2 | -1.77 Million USD | 0.0% |
| 2023 FY | -2.13 Million USD | -164.26% |
| 2023 Q4 | -2.13 Million USD | -628.74% |
| 2023 Q2 | 1.95 Million USD | -24.8% |
| 2023 Q1 | 2.59 Million USD | -21.94% |
| 2023 Q3 | -293.42 Thousand USD | -115.02% |
| 2022 Q3 | 2.44 Million USD | -23.76% |
| 2022 Q2 | 3.2 Million USD | 44.49% |
| 2022 Q4 | 3.32 Million USD | 36.01% |
| 2022 FY | 3.32 Million USD | -3.72% |
| 2022 Q1 | 2.22 Million USD | -35.74% |
| 2021 Q2 | 766.84 Thousand USD | -73.71% |
| 2021 Q1 | 2.91 Million USD | 19.61% |
| 2021 Q4 | 3.45 Million USD | 45.6% |
| 2021 FY | 3.45 Million USD | 41.72% |
| 2021 Q3 | 2.37 Million USD | 209.54% |
| 2020 FY | 2.43 Million USD | 10.2% |
| 2020 Q1 | 2.43 Million USD | 9.94% |
| 2020 Q2 | 2.43 Million USD | 0.06% |
| 2020 Q3 | 1.93 Million USD | -20.42% |
| 2020 Q4 | 2.43 Million USD | 25.88% |
| 2019 Q3 | 1.95 Million USD | 108.05% |
| 2019 Q4 | 2.21 Million USD | 13.46% |
| 2019 Q1 | 691.38 Thousand USD | -55.44% |
| 2019 FY | 2.21 Million USD | 34.06% |
| 2019 Q2 | 937.47 Thousand USD | 35.59% |
| 2018 Q3 | 39.27 Thousand USD | -26.88% |
| 2018 FY | 1.65 Million USD | -18.64% |
| 2018 Q4 | 1.55 Million USD | 3850.68% |
| 2018 Q2 | 53.7 Thousand USD | 35.94% |
| 2018 Q1 | 39.51 Thousand USD | 59.63% |
| 2017 FY | 2.02 Million USD | 690.19% |
| 2017 Q3 | -823.89 USD | -100.65% |
| 2017 Q4 | 24.75 Thousand USD | 3104.18% |
| 2017 Q2 | 126.89 Thousand USD | 458.49% |
| 2017 Q1 | 22.72 Thousand USD | 138.41% |
| 2016 Q3 | -343.74 Thousand USD | -34.7% |
| 2016 Q1 | -25.03 Thousand USD | -117.19% |
| 2016 FY | -343.74 Thousand USD | -133.21% |
| 2016 Q2 | -255.19 Thousand USD | -919.54% |
| 2016 Q4 | -59.15 Thousand USD | 82.79% |
| 2015 Q3 | 1.03 Million USD | -29.48% |
| 2015 FY | 1.03 Million USD | 28.08% |
| 2015 Q1 | 1.15 Million USD | 9.16% |
| 2015 Q2 | 1.46 Million USD | 27.01% |
| 2015 Q4 | 145.64 Thousand USD | -85.93% |
| 2014 Q3 | 808.04 Thousand USD | -68.4% |
| 2014 Q2 | 2.55 Million USD | -1.39% |
| 2014 Q1 | 2.59 Million USD | -9.94% |
| 2014 FY | 808.04 Thousand USD | 4.36% |
| 2014 Q4 | 1.05 Million USD | 31.01% |
| 2013 Q4 | 2.87 Million USD | 271.86% |
| 2013 FY | 774.28 Thousand USD | -72.51% |
| 2013 Q1 | 497.9 Thousand USD | 43.79% |
| 2013 Q2 | 585.9 Thousand USD | 17.68% |
| 2013 Q3 | 774.28 Thousand USD | 32.15% |
| 2012 Q2 | 3.41 Million USD | -3.3% |
| 2012 Q1 | 3.53 Million USD | 294.03% |
| 2012 Q4 | 346.26 Thousand USD | -87.7% |
| 2012 Q3 | 2.81 Million USD | -17.59% |
| 2012 FY | 2.81 Million USD | -27.14% |
| 2011 Q1 | 2.38 Million USD | -9.81% |
| 2011 Q2 | 763.09 Thousand USD | -68.01% |
| 2011 Q4 | 896.82 Thousand USD | -76.8% |
| 2011 Q3 | 3.86 Million USD | 406.49% |
| 2011 FY | 3.86 Million USD | 252.17% |
| 2010 FY | 1.09 Million USD | 20404.61% |
| 2010 Q4 | 2.64 Million USD | 120.2% |
| 2010 Q3 | 1.2 Million USD | 5064.25% |
| 2010 Q2 | -24.19 Thousand USD | 41.0% |
| 2010 Q1 | -41.01 Thousand USD | 58.56% |
| 2009 FY | -5405.00 USD | 97.17% |
| 2009 Q3 | -157.86 Thousand USD | 0.0% |
| 2009 Q4 | -98.97 Thousand USD | 37.3% |
| 2008 FY | -190.83 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.13 Thousand CAD | 358.83% |
| Ayurcann Holdings Corp. | 69.97 Thousand CAD | 3155.61% |
| Blueberries Medical Corp. | -805.35 Thousand CAD | -165.509% |
| The BC Bud Corporation | 225.15 Thousand CAD | 1049.703% |
| BioNxt Solutions Inc. | 4.53 Million CAD | 147.198% |
| CordovaCann Corp. | 6.13 Million CAD | 134.877% |
| Christina Lake Cannabis Corp. | 4.62 Million CAD | 146.202% |
| Captor Capital Corp. | -5.41 Million CAD | 60.479% |
| City View Green Holdings Inc. | 1.49 Million CAD | 242.721% |
| 1CM Inc. | 3.31 Million CAD | 164.503% |
| Global Hemp Group Inc. | 3.55 Million CAD | 160.197% |
| Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | 114.757% |
| IM Cannabis Corp. | 11.96 Million CAD | 117.865% |
| Lobe Sciences Ltd. | 192.35 Thousand CAD | 1211.664% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | 186.434% |
| Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 63.85% |
| Nextleaf Solutions Ltd. | -449.15 Thousand CAD | -376.071% |
| Ovation Science Inc. | 143.76 Thousand CAD | 1587.337% |
| Pharmadrug Inc. | 1.2 Million CAD | 277.202% |
| Captiva Verde Wellness Corp. | 186.26 Thousand CAD | 1248.011% |
| RAMM Pharma Corp. | -4.71 Million CAD | 54.617% |
| RIV Capital Inc. | -101.38 Million CAD | 97.891% |
| Revive Therapeutics Ltd. | -797.85 Thousand CAD | -168.006% |
| Red White & Bloom Brands Inc. | 259.87 Million CAD | 100.823% |
| SLANG Worldwide Inc. | 20.83 Million CAD | 110.265% |
| 1933 Industries Inc. | 16.47 Million CAD | 112.976% |
| Red Light Holland Corp. | -13.56 Million CAD | 84.232% |
| Top Strike Resources Corp. | 13.24 Million CAD | 116.14% |
| Xebra Brands Ltd. | -102.41 Thousand CAD | -1987.802% |
| Adastra Holdings Ltd. | 2.2 Million CAD | 197.004% |